These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 2031657

  • 1. T-cell antigenic sites involved in myasthenia gravis: correlations with antibody titre and disease severity.
    Berrih-Aknin S, Cohen-Kaminsky S, Lepage V, Neumann D, Bach JF, Fuchs S.
    J Autoimmun; 1991 Feb; 4(1):137-53. PubMed ID: 2031657
    [Abstract] [Full Text] [Related]

  • 2. T-cell recognition of acetylcholine receptor provides a reliable means for monitoring autoimmunity to acetylcholine receptor in antibody-negative myasthenia gravis patients.
    Oshima M, Deitiker PR, Smith RG, Mosier D, Atassi MZ.
    Autoimmunity; 2012 Mar; 45(2):153-60. PubMed ID: 21985279
    [Abstract] [Full Text] [Related]

  • 3. T-helper epitopes on human nicotinic acetylcholine receptor in myasthenia gravis.
    Moiola L, Protti MP, Manfredi AA, Yuen MH, Howard JF, Conti-Tronconi BM.
    Ann N Y Acad Sci; 1993 Jun 21; 681():198-218. PubMed ID: 7689306
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Immunomodulation by a dual altered peptide ligand of autoreactive responses to the acetylcholine receptor of peripheral blood lymphocytes of patients with myasthenia gravis.
    Dayan M, Sthoeger Z, Neiman A, Abarbanel J, Sela M, Mozes E.
    Hum Immunol; 2004 Jun 21; 65(6):571-7. PubMed ID: 15219376
    [Abstract] [Full Text] [Related]

  • 6. Immuno-suppressive peptides for a human T cell clone autoreactive to a unique acetylcholine receptor alpha subunit peptide presented by the disease-susceptible HLA-DQ6 in infant-onset myasthenia gravis.
    Kanai T, Nomura Y, Segawa M, Takagi K, Senju S, Matsushita S, Nishimura Y.
    Hum Immunol; 1997 Jun 21; 56(1-2):28-38. PubMed ID: 9455491
    [Abstract] [Full Text] [Related]

  • 7. T-cell reactivity in myasthenia gravis.
    Newsom-Davis J, Harcourt G, Sommer N, Beeson D, Willcox N, Rothbard JB.
    J Autoimmun; 1989 Jun 21; 2 Suppl():101-8. PubMed ID: 2476140
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Genetic restriction of autoreactive acetylcholine receptor-specific T lymphocytes in myasthenia gravis.
    Hohlfeld R, Conti-Tronconi B, Kalies I, Bertrams J, Toyka KV.
    J Immunol; 1985 Oct 21; 135(4):2393-9. PubMed ID: 2411794
    [Abstract] [Full Text] [Related]

  • 11. Suppression of experimental autoimmune myasthenia gravis by epitope-specific neonatal tolerance to synthetic region alpha 146-162 of acetylcholine receptor.
    Shenoy M, Oshima M, Atassi MZ, Christadoss P.
    Clin Immunol Immunopathol; 1993 Mar 21; 66(3):230-8. PubMed ID: 7679342
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Specific activation of lymphocytes against acetylcholine receptor in the thymus in myasthenia gravis.
    Fujii Y, Hashimoto J, Monden Y, Ito T, Nakahara K, Kawashima Y.
    J Immunol; 1986 Feb 01; 136(3):887-91. PubMed ID: 2416838
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.